KeyBanc analyst Paul Knight reiterated an Overweight rating and $80.00 price target on Bio-Techne Corp. (NASDAQ: TECH).The analyst commented, "While ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE